This page shows results related to Alaway and Disturbance In Attention from the FDA Adverse Event Reporting System (AERS). The adverse event Disturbance In Attention has been reported to the FDA a total of 1 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Disturbance In Attention is 1. The chart below compares this proportional reporting ratio of Disturbance In Attention for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Disturbance In Attention.
Disturbance In Attention | |
Alaway | 1 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Disturbance In Attention, why were they taking Alaway?
Eye Pruritus | 1 |
Which medications reported to the FDA are most commonly associated with Disturbance In Attention?
Chantix | 1018 |
Lyrica | 967 |
Paxil | 846 |
Strattera | 558 |
Vioxx | 458 |
Paroxetine Hcl | 420 |
Cymbalta | 407 |
Effexor Xr | 326 |
Tysabri | 313 |
Oxycontin | 280 |
Neurontin | 253 |
Show More |